Stoke Therapeutics, Inc. (STOK) Net income 2018–2025
Stoke Therapeutics, Inc. (STOK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.9MFY2025 · since FY2018: -$12.5M → -$6.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.9M | +92.3% |
| FY2024 | -$89.0M | +15.0% |
| FY2023 | -$104.7M | -3.6% |
| FY2022 | -$101.1M | -17.8% |
| FY2021 | -$85.8M | -64.2% |
| FY2020 | -$52.2M | -61.6% |
| FY2019 | -$32.3M | -158.2% |
| FY2018 | -$12.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice